AstraZeneca in Gothenburg

  • GOTHENBURG
  • SWEDEN

Our vision is to be one of the best R&D sites in the world.

Gothenburg is one of AstraZeneca’s three strategic, global R&D centres, alongside Cambridge and Gaithersburg, and plays a central role in our mission to deliver life-changing medicines to patients.

Explore Gothenburg




Global Gothenburg: A cross-section of AstraZeneca – on one site

With more than 2,400 employees from 50 countries, the vibrant Gothenburg site helps to support the entire life-cycle of AstraZeneca medicines, from drug discovery and clinical trials, to global commercialisation and product maintenance. Looking to the future, AZ Gothenburg has initiated the creation of a new, global cluster for health and life science, as part of the GoCo Health Innovation City project.



From idea to new medicine

Our teams in Gothenburg have broad scientific expertise and capabilities and work across the entire life-cycle of our medicines.


Lab4Life: Building state-of-the-art shared labs and offices for the future

Lab4Life is a driving force in our work to make Gothenburg one of the best R&D sites in the world. The philosophy of Lab4Life is to create flexible lab and office working environments that encourage collaboration between scientists from different therapy areas and disciplines. Lab4Life includes more than 10 new Centres of Excellence, including centres for Chemistry, Mass Spectrometry, Cells, Sample Management, and more. The Lab4Life initiative has already inspired other labs across both our company and the industry. Watch this new film to follow one of our scientists, Anita, as she spends a day in these new, shared state-of-the-art spaces.


Open for collaboration


100 million USD

Investment in Karolinska Institutet partnership

>100

Academic collaborations signed 2014/2015 by Gothenburg site

70%

of cardiovascular and metabolic disease pipeline involves collaboration



BioVentureHub: a new way to collaborate

The AstraZeneca BioVentureHub is an exciting concept. We offer some of our office and laboratory space in Gothenburg to biotech companies and academic groups. This is a cost-effective opportunity for biotech start-ups to benefit from our scientific expertise and facilities, plus opportunities for future collaborations. We benefit through increasing external interaction and vibrancy while also nurturing the Scandinavian life science ecosystem.




Gothenburg key facts

2,400

Employees on site

2000

Scientists from 50 countries

600

Scientists with PhDs

30

Professors among our scientists


Our community commitment

AstraZeneca works actively to foster interest in life sciences among children and young adults in Sweden. We also support programmes under the umbrella of our global Young Health Program, which focuses on mental and physical health among children and adolescents.